Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,940 public trials 1,514 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

NCT00049465

Conditions
Adnexal Diseases, Behavior, Behavioral Symptoms, +105 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • AMC Cancer Research Center Denver, Colorado, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Shands Hospital and Clinics, University of Florida Gainesville, Florida, United States
View Trial Details
Completed

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

NCT00045292

Conditions
Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +108 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States
  • Baylor University Medical Center Dallas, Texas, United States
View Trial Details
Completed

A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer

NCT00544960

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Durham, North Carolina, United States
  • Research Site Arkhangelsk, Russia
  • Research Site Chelyabinsk, Russia
  • Research Site Kaliningrad, Russia
View all 18 locations
View Trial Details
Completed

Improvement of Self Management for Oncologic Patients With Pain

NCT00779597

Conditions
Cancer, Neoplasms, Neurologic Manifestations, +3 more
Locations
  • University Hospital rechts der Isar, Munich Technical University Munich, Bavaria, Germany
  • Martin-Luther-University Halle-Wittenberg Halle, Saxony-Anhalt, Germany
  • University Hospital Halle, Martin-Luther-University Halle-Wittenberg Halle, Saxony-Anhalt, Germany
View Trial Details
Completed

Safety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's Lymphoma

NCT00440388

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Hematology Oncology Associates Phoenix, Arizona, United States
  • Rocky Mountain Cancer Center-Aurora Aurora, Colorado, United States
  • Florida Cancer Institute Hudson, Florida, United States
View all 28 locations
View Trial Details

Related conditions